AMGEN BIOSIMILARS Logo (EUIPO, 05/08/2017)
EUIPOProtect this trademark from copycats!
With our trademark monitoring alerts, you are automatically notified by email about copycats and free riders.
The Union trademark AMGEN BIOSIMILARS was filed as Figurative mark on 05/08/2017 at the European Union Intellectual Property Office.
It was registered as a trademark on 10/13/2017.
The current status of the mark is "Trademark registered".
Logodesign (Wiener Klassifikation)
#Other parts of the human body, DNA band, cells, brains, sperms, hair roots (also 2.9.12) #Backgrounds, in words or numerals, divided into two, horizontally #Blue #Grey
| Trademark form | Figurative mark |
| File reference | 016688905 |
| Application date | May 8, 2017 |
| Publication date | July 6, 2017 |
| Entry date | October 13, 2017 |
| Expiration date | May 8, 2027 |
Trademark owner
One Amgen Center Drive
91320-1799 Thousand Oaks,
US
91320-1799 Thousand Oaks,
US
Trademark representatives
2Amsterdam Eduard van Beinumstraat 10 3rd Floor
1077 CZ Amsterdam
NL
goods and services
5
Pharmaceutical preparations; pharmaceutical preparations and substances used for the treatment of bone, joint, vertebral column, intestine, colon, skin, lung, eye, breast, ovary, cervix, stomach, bladder, kidney, head, brain, neck, and blood diseases and disorders; pharmaceutical preparations and substances for the treatment of autoimmune, immune system, inflammatory, inflammatory bowel, gastrointestinal, genitourinary, musculoskeletal, dermatological, pulmonary, respiratory, oncological, hepatological, lymphomas, leukemias, ophthalmic, transplant rejection, cardiovascular, endocrine, neurological, sleep, muscular, and psychiatric diseases and disorders; pharmaceutical preparations and substances used for the treatment of arthritis, rheumatoid arthritis, psoriatic arthritis, ankylosing spondylitis, axial spondyloarthritis, juvenile idiopathic arthritis, enthesitis related arthritis, osteoarthritis, peripheral spondyloarthritis, polymyalgia rheumatic, spondyloarthropathies, acute disc prolapse, inflammatory bowel disease; pharmaceutical preparations and substances used for the treatment of crohn's disease, ulcerative colitis, intestinal behçet's disease, chronic pouchitis, small bowel lesions, hermansky-pudlak syndrome, autoimmune pancreatitis, multiple myeloma, multiple sclerosis, systemic lupus erythematosus, lupus nephritis, chronic inflammatory demyelinating polyneuropathy, autoimmune anemia; pharmaceutical preparations and substances used for the treatment of autoimmune hemolytic anemia, pure red cell aplasia, idiopathic thrombocytopenic purpura, evans syndrome, type 1 diabetes mellitus, sjogren's syndrome, encephalitis, igg4-related disease, devic's disease, myositis, psoriasis, psoriasis vulgaris, psoriasis arthropica, plaque psoriasis, palmoplantar psoriasis, hidradenitis suppurativa, bullous skin disorder, pemphigus, pemphigoid, kawasaki disease, interstitial cystitis; pharmaceutical preparations and substances used for the treatment of sleep apnea, sarcoidosis, retinal vascular disorders, age-related macular degeneration, refractory diabetic macular edema, uveitis, childhood uveitis, uveitic macular edema, choroidal neovascularization, graves' ophthalmopathy, pyoderma gangrenosum, giant cell arteritis, netherton syndrome, anaplastic thyroid cancer; pharmaceutical preparations and substances used for the treatment of breast cancer, ovarian cancer, cervical cancer, gastric cancer, colorectal cancer, non-squamous non-small cell lung cancer, glioblastoma, renal cell carcinoma, head and neck cancer, non-hodgkin's lymphoma, chronic lymphocytic leukemia, lymphocyte predominant subtype of hodgkin's lymphoma, vasculitis; pharmaceutical preparations and substances used for the treatment of granulomatosis with polyangiitis, microscopic polyangiitis, graft-versus-host disease, graft-versus-host disease following allogenic hematopoietic stem cell transplantation, graft-versus-host disease following keratoprosthesis, kidney transplant, asthma, chronic fatigue syndrome, major depression, and bipolar depression
41
Providing online publications in the nature of brochures and newsletters in the fields of pharmaceuticals, biosimilars, medicines and health; arranging and conducting classes, seminars and workshops in the fields of pharmaceuticals, biosimilars, medicines and health; educational services, namely, programs about pharmaceuticals, biosimilars, medicines and health accessible by means of audio, video, web-based applications, mobile phone applications, and computer networks; educational services, namely, conducting programs in the fields of pharmaceuticals, biosimilars, medicines and health
42
Research and development of pharmaceutical preparations and biosimilars; research and development in the pharmaceutical and biotechnology fields; medical and scientific research information in the fields of pharmaceutical preparations, biosimilars and clinical trials; providing online computer software used to access, manage, update and display electronic databases in the fields of pharmaceutical preparations and biosimilars
44
Providing websites featuring information about pharmaceutical preparations and biosimilars; pharmaceutical advisory services
Trademark history
| Date | Document number | Area | Entry |
|---|---|---|---|
| November 6, 2023 | Change Representative, Published |
ID: 11016688905